Log In
BCIQ
Print this Print this
 

RVT-501 (formerly E6005)

  Manage Alerts
Collapse Summary General Information
Company Eisai Co. Ltd.
DescriptionTopical phosphodiesterase-4 inhibitor
Molecular Target Phosphodiesterase-4 (PDE-4)
Mechanism of ActionPhosphodiesterase-4 (PDE-4) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDermatitis
Indication DetailsTreat atopic dermatitis
Regulatory Designation
PartnerRoivant Sciences Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/20/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today